Nissay Asset Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.76M | Buy |
115,276
+6,976
| +6% | +$465K | 0.03% | 295 |
|
|
2026
Q1 | $6.8M | Buy |
108,300
+2,208
| +2% | +$154K | 0.04% | 271 |
|
|
2025
Q4 | $7.04M | Buy |
106,092
+4,985
| +5% | +$322K | 0.04% | 267 |
|
|
2025
Q3 | $6.8M | Buy |
101,107
+1,747
| +2% | +$138K | 0.04% | 270 |
|
|
2025
Q2 | $8.67M | Buy |
99,360
+3,285
| +3% | +$257K | 0.05% | 234 |
|
|
2025
Q1 | $6.56M | Buy |
96,075
+7,497
| +8% | +$612K | 0.04% | 270 |
|
|
2024
Q4 | $7.11M | Sell |
88,578
-12,956
| -13% | -$959K | 0.04% | 261 |
|
|
2024
Q3 | $6.81M | Buy |
101,534
+8,656
| +9% | +$711K | 0.04% | 262 |
|
|
2024
Q2 | $10.5M | Buy |
92,878
+8,953
| +11% | +$1.13M | 0.07% | 182 |
|
|
2024
Q1 | $11.6M | Buy |
83,925
+16,289
| +24% | +$2.05M | 0.08% | 168 |
|
|
2023
Q4 | $8.39M | Buy |
67,636
+4,747
| +8% | +$485K | 0.07% | 175 |
|
|
2023
Q3 | $5.87M | Buy |
62,889
+3,527
| +6% | +$398K | 0.05% | 212 |
|
|
2023
Q2 | $7.63M | Buy |
59,362
+476
| +0.8% | +$57.6K | 0.07% | 177 |
|
|
2023
Q1 | $6.84M | Sell |
58,886
-12,778
| -18% | -$1.43M | 0.06% | 181 |
|
|
2022
Q4 | $8.12M | Buy |
71,664
+6,395
| +10% | +$702K | 0.08% | 159 |
|
|
2022
Q3 | $5.26M | Buy |
65,269
+2,089
| +3% | +$177K | 0.06% | 208 |
|
|
2022
Q2 | $4.71M | Buy |
63,180
+5,996
| +10% | +$547K | 0.05% | 224 |
|
|
2022
Q1 | $7.31M | Buy |
57,184
+1,028
| +2% | +$112K | 0.06% | 185 |
|
|
2021
Q4 | $7.54M | Buy |
56,156
+4,396
| +8% | +$632K | 0.06% | 195 |
|
|
2021
Q3 | $7.08M | Buy |
51,760
+1,732
| +3% | +$218K | 0.06% | 185 |
|
|
2021
Q2 | $5.34M | Buy |
50,028
+10,016
| +25% | +$962K | 0.05% | 226 |
|
|
2021
Q1 | $3.6M | Sell |
40,012
-828
| -2% | -$77.7K | 0.04% | 291 |
|
|
2020
Q4 | $3.77M | Buy |
40,840
+396
| +1% | +$35.4K | 0.06% | 259 |
|
|
2020
Q3 | $4.17M | Sell |
40,444
-7,408
| -15% | -$774K | 0.07% | 201 |
|
|
2020
Q2 | $4.85M | Buy |
47,852
+3,476
| +8% | +$311K | 0.09% | 203 |
|
|
2020
Q1 | $2.99M | Buy |
44,376
+2,412
| +6% | +$150K | 0.08% | 245 |
|
|
2019
Q4 | $2.29M | Buy |
41,964
+12,224
| +41% | +$580K | 0.05% | 365 |
|
|
2019
Q3 | $1.11M | Buy |
29,740
+1,752
| +6% | +$68.1K | 0.03% | 466 |
|
|
2019
Q2 | $1.05M | Sell |
27,988
-3,204
| -10% | -$101K | 0.03% | 485 |
|
|
2019
Q1 | $929K | Buy |
31,192
+1,684
| +6% | +$59.2K | 0.02% | 509 |
|
|
2018
Q4 | $884K | Buy |
+29,508
| New | +$936K | 0.03% | 477 |
|
Other funds holding DXCM
Nissay Asset Management's DXCM Position: Q2 2026 in Review
Nissay Asset Management increased its DexCom (DXCM) stake by 6.4% in Q2 2026, buying an estimated $465K and bringing the position to 115,276 shares worth $7.76M. The position accounts for 0.03% of the portfolio, ranked #295.
Nissay Asset Management first reported a position in DXCM in Q4 2018 and has held it in 31 quarters since. The position peaked at $11.6M in Q1 2024. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Nissay Asset Management held 115,276 shares of DexCom worth $7.76M as of Q2 2026.
- Nissay Asset Management bought 6,976 DexCom shares in Q2 2026, an estimated $465K.
- DexCom made up 0.03% of Nissay Asset Management's portfolio in Q2 2026, its #295 holding.
- Nissay Asset Management first reported a position in DexCom in Q4 2018 and has held it in 31 quarters since.
- Nissay Asset Management's DexCom position peaked at $11.6M in Q1 2024.
- 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Nissay Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.